J. Scott Wolchko - Jul 21, 2022 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
President and CEO, Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Stock symbol
FATE
Transactions as of
Jul 21, 2022
Transactions value $
-$1,088,852
Form type
4
Date filed
7/25/2022, 06:18 PM
Previous filing
Apr 25, 2022
Next filing
Jan 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $81K +30K +6.95% $2.70 462K Jul 21, 2022 Direct F1
transaction FATE Common Stock Sale -$352K -10.8K -2.35% $32.54* 451K Jul 21, 2022 Direct F1, F2
transaction FATE Common Stock Sale -$634K -19.2K -4.25% $33.07* 432K Jul 21, 2022 Direct F1, F3
transaction FATE Common Stock Options Exercise $16.9K +6.25K +1.45% $2.70 438K Jul 22, 2022 Direct F1
transaction FATE Common Stock Sale -$91.6K -2.92K -0.67% $31.33* 435K Jul 22, 2022 Direct F1, F4
transaction FATE Common Stock Sale -$88.1K -2.7K -0.62% $32.61* 432K Jul 22, 2022 Direct F1, F5
transaction FATE Common Stock Sale -$20.6K -620 -0.14% $33.28* 432K Jul 22, 2022 Direct F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -30K -82.77% $0.00 6.25K Jul 21, 2022 Common Stock 30K $2.70 Direct F1, F7
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -6.25K -100% $0.00* 0 Jul 22, 2022 Common Stock 6.25K $2.70 Direct F1, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 10, 2020.
F2 Represents the weighted average sale price of the shares sold ranging from $31.82 to $32.81 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 6.
F3 Represents the weighted average sale price of the shares sold ranging from $32.83 to $33.33 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $30.99 to $31.74 per share.
F5 Represents the weighted average sale price of the shares sold ranging from $32.02 to $33.01 per share.
F6 Represents the weighted average sale price of the shares sold ranging from $33.03 to $33.67 per share.
F7 This option is fully vested.